Episode Details

Canada’s tax watchdog is suing Eli Lilly over alleged underpayment of taxes in 2020, focusing on how the company priced goods bought from its Irish subsidiary — a move that could expose millions in unpaid Canadian taxes. The CRA spotted suspiciously low profit margins and is demanding documents to investigate whether internal transactions were mispriced to shift profits overseas. While no guilt has been proven, this audit could reshape how global pharma giants handle their Canadian tax obligations — especially as transfer pricing rules aim to prevent tax avoidance.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/f81e198eda901faf